Clinical Trial Update: Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating distinct immunophenotypes to validate and optimize immunotherapy strategies for systemic lupus erythematosus; the study was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: TERMINATED | Results posted: 2025-09-09